Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$1.2M Buy
20,207
+536
+3% +$32.3K 0.17% 231
2017
Q2
$1.27M Buy
+19,671
New +$1.3M 0.18% 228
2016
Q3
Sell
-2,791
Closed -$216K 635
2016
Q2
$216K Sell
2,791
-5,832
-68% -$441K 0.05% 488
2016
Q1
$633K Sell
8,623
-4,661
-35% -$315K 0.17% 259
2015
Q4
$926K Sell
13,284
-7,934
-37% -$581K 0.26% 132
2015
Q3
$1.53M Sell
21,218
-37,019
-64% -$2.87M 0.36% 54
2015
Q2
$4.63M Buy
58,237
+24,873
+75% +$2.04M 0.59% 35
2015
Q1
$2.71M Buy
33,364
+6,115
+22% +$469K 0.37% 101
2014
Q4
$2.06M Buy
+27,249
New +$2.05M 0.42% 82

Other funds holding DVA

GAM Systematic's DVA Position: Q3 2017 in Review

GAM Systematic increased its DaVita (DVA) stake by 2.7% in Q3 2017, buying an estimated $32.3K and bringing the position to 20,207 shares worth $1.2M. The position accounts for 0.17% of the portfolio, ranked #231.

GAM Systematic first reported a position in DVA in Q4 2014 and has held it in 9 quarters since. The position peaked at $4.63M in Q2 2015. 443 funds tracked by Wall St. Rank hold DVA as of Q3 2017.

  • GAM Systematic held 20,207 shares of DaVita worth $1.2M as of Q3 2017.
  • GAM Systematic bought 536 DaVita shares in Q3 2017, an estimated $32.3K.
  • DaVita made up 0.17% of GAM Systematic's portfolio in Q3 2017, its #231 holding.
  • GAM Systematic first reported a position in DaVita in Q4 2014 and has held it in 9 quarters since.
  • GAM Systematic's DaVita position peaked at $4.63M in Q2 2015.
  • 443 funds tracked by Wall St. Rank held DaVita as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.